Bufexamac

CAS No.

2438-72-4

MDL No.

MFCD00078936

C₁₂H₁₇NO₃

223.27

InChI Key

MXJWRABVEGLYDG-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability
250 mg	98%	$9	In Stock
1 g	98%	$10	In Stock
5 g	98%	$20	In Stock
25 g	98%	$76	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

250 mg

98%

In Stock

1 g

98%

$10

In Stock

5 g

98%

$20

In Stock

25 g

98%

$76

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

Bufexamac is a hydroxamic acid derived from phenylacetamide with a butoxy group at the C-4 position of the benzene ring. It exhibits anti-inflammatory, analgesic, and antipyretic properties, functioning as a non-narcotic analgesic, non-steroidal anti-inflammatory drug, and antipyretic. It is also classified as a hydroxamic acid and an aromatic ether.

CAS No.	2438-72-4
Product Name	Bufexamac

Associated Conditions

Arthralgia·Myalgia·rheumatic disease

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Documentation

Bufexamac

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Related Articles

Allergic contact dermatitis with spreading over extensive regions due to topical use of 5% bufexamac ointment.

Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group.

[Epidemiologic surveillance of contact allergens. The "monitoring series" of IVDK (Information Network ofDermatologic Clinics for Detection and Scientific Evaluation of Contact Allergy].

An integrative approach to eczema (atopic dermatitis).

Documentation